The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette‐based study
Abstract
BACKGROUND: Genetic counseling and testing is recommended for women at high but not average risk of ovarian cancer. National estimates of physician adherence to genetic counseling and testing recommendations are lacking. METHODS: Using a vignette‐based study, we surveyed 3200 United States family physicians, general internists, and obstetrician/gynecologists and received 1878 (62%) responses. The questionnaire included an annual examination vignette asking about genetic counseling and testing. The vignette varied patient age, race, insurance status, and ovarian cancer risk. Estimates of physician adherence to genetic counseling and testing recommendations were weighted to the United States primary care physician population. Multivariable logistic regression identified independent patient and physician predictors of adherence. RESULTS: For average‐risk women, 71% of physicians self‐reported adhering to recommendations against genetic counseling or testing. In multivariable modeling, predictors of adherence against referral/testing included black versus white race (relative risk [RR], 1.16; 95% confidence interval [CI], 1.03‐1.31), Medicaid versus private insurance (RR, 1.15; 95% CI, 1.02‐1.29), and rural versus urban location. Among high‐risk women, 41% of physicians self‐reported adhering to recommendations to refer for genetic counseling or testing. Predictors of adherence for referral/testing were younger patient age [35 vs 51 years [RR, 1.78; 95% CI, 1.41‐2.24]), physician sex (female vs male [RR, 1.30; 95% CI, 1.07‐1.64]), and obstetrician/gynecologist versus family medicine specialty (RR, 1.64; 95% CI, 1.31‐2.05). For both average‐risk and high‐risk women, physician‐estimated ovarian cancer risk was the most powerful predictor of recommendation adherence. CONCLUSION: Physicians reported that they would refer many average‐risk women and would not refer many high‐risk women for genetic counseling/testing. Intervention efforts, including promotion of accurate risk assessment, are needed. Cancer 2011;. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Barriers to family history screening and genetic counseling referral include insufficient knowledge of HBOC and inability to intuit risk, [31–35] lack of time and competing priorities in the primary care encounter, [30, 36] and inadequate reporting of family history in medical records [26, 37].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 2×
“Cumulative risk for developing ovarian cancer incidence by age 70 is 40% for BRCA1 carriers and 18% for BRCA2 carriers.(1) Women with a personal or family history indicative of a BRCA1/2 mutation may benefit from genetic counseling and testing.”
BackgroundRebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Research works printed but not linked: 33
- 10.7326/0003-4819-143-5-200509060-00011 · DOI · Paper page
- 10.1097/AOG.0b013e3181a106d4 · DOI · Paper page
- Mouchawar J, 2001, Colorado family physicians' knowledge of hereditary breast cancer and related practice, J Cancer Educ, 16, 33
- 10.1097/AOG.0b013e3181da08d7 · DOI
- 10.3122/jabfm.2009.03.080153 · DOI
- 10.1097/01.GIM.0000055198.63593.32 · DOI
- 10.1111/j.1525-1497.2004.30280.x · DOI
- 10.1097/01.GIM.0000086477.00766.C9 · DOI
- Wideroff L, 2003, Physician use of genetic testing for cancer susceptibility: results of a national survey, Cancer Epidemiol Biomarkers Prev, 12, 295
- 10.1097/01.gim.0000177418.24176.9b · DOI
- 10.1016/j.ypmed.2004.09.041 · DOI
- 10.1016/j.cdp.2007.08.003 · DOI
- 10.1097/GIM.0b013e3181770184 · DOI · Paper page
- 10.1158/1055-9965.EPI-07-2879 · DOI
- 10.1002/ajmg.a.32643 · DOI
- 10.1016/j.amjsurg.2009.06.010 · DOI
- 10.1016/j.amepre.2010.09.027 · DOI · Paper page
- Dillman DA, 2007, Mail and internet surveys: the tailored design method
- 10.2747/0272-3638.20.8.727 · DOI · Paper page
- 10.1016/j.annemergmed.2005.04.016 · DOI · Paper page
- 10.1046/j.1525-1497.2000.04079.x · DOI · Paper page
- 10.1093/aje/kwp440 · DOI · Paper page
- 10.1016/j.socscimed.2007.09.009 · DOI · Paper page
- 2010, Vital signs: breast cancer screening among women aged 50‐74 years—United States, 2008, MMWR Morb Mortal Wkly Rep, 59, 813
- 10.1097/MLR.0b013e31817893b1 · DOI
- 10.1002/cncr.25215 · DOI
- 10.1007/s10552-006-0078-7 · DOI
- 10.1002/cncr.20692 · doi:10.1002/cncr.20692
- 10.1016/j.amepre.2008.05.021 · DOI
- 10.1097/MLR.0b013e3181ca4015 · DOI
- 10.1001/jama.283.13.1715 · DOI · Paper page
- 10.1097/GIM.0b013e3181b9b04a · DOI
- Watson E, 2001, Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial, Br J Gen Pract, 51, 817
Cited by
Schwartz, M. D., Valdimarsdottir, H. B., Peshkin, B. N., Mandelblatt, J., Nusbaum, R., Huang, A.-T., Chang, Y., Graves, K., Isaacs, C., Wood, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.3226 · Cited by 253
Silverman, T. B., Vanegas, A., Marte, A., Mata, J., Sin, M., Ramirez, J. C. R., Tsai, W.-Y., Crew, K. D., & Kukafka, R. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3442-x · Cited by 19
Metadata
- Authors
- Trivers, K. F., Baldwin, L., Miller, J. W., Matthews, B., Andrilla, C. H. A., Lishner, D. M., & Goff, B. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-07-25
- Volume
- 117
- Issue
- 23
- Pages
- 5334-5343
- ISSN
- 0008-543X
- 1097-0142
- Cited by
- 86
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette‐based study. https://app.cochat.ai/papers/10.1002/cncr.26166
- The paper
- Trivers, K. F., Baldwin, L., Miller, J. W., Matthews, B., Andrilla, C. H. A., Lishner, D. M., & Goff, B. A. (2011). Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette‐based study. Cancer. https://doi.org/10.1002/cncr.26166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.